COCP - Cocrystal Pharma Inc
1.57
0.095 6.051%
Share volume: 27,366
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.48
0.09
0.06%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-13-2024 | 08-14-2023 | 11-13-2023 | 11-13-2024 | 05-13-2024 | 08-14-2024 | 11-13-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 5.111 M | 4.339 M | 6.043 M | 5.666 M | 4.158 M | 5.448 M | 5.042 M | |
| Selling general and admin | 1.204 M | 1.538 M | 1.849 M | 1.399 M | 1.208 M | 1.140 M | 1.800 M | |
| Research and development | 3.907 M | 2.801 M | 4.194 M | 4.267 M | 2.950 M | 4.308 M | 3.242 M | |
| Total expenses | 5.111 M | 4.339 M | 4.443 M | 4.666 M | 4.158 M | 5.448 M | 5.042 M | |
| -15.10% | 2.40% | 5.02% | -10.89% | 31.02% | -7.45% | |||
| Operating income | -5.111 M | -4.339 M | -4.443 M | -4.666 M | -4.158 M | -5.448 M | -5.042 M | |
| Ebit | -5.189 M | -4.306 M | -4.485 M | -4.644 M | -4.176 M | -5.494 M | -5.050 M | |
| Pretax income | -5.189 M | -4.166 M | -4.165 M | -4.464 M | -3.956 M | -5.343 M | -4.939 M | |
| -19.71% | -0.02% | 7.18% | -11.38% | 35.06% | -7.56% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.189 M | -4.166 M | -4.165 M | -4.464 M | -3.956 M | -5.343 M | -4.939 M | |
| 19.71% | 0.02% | -7.18% | 11.38% | -35.06% | 7.56% |
